BRCA1/2 signaling and homologous recombination deficiency in breast and ovarian cancer Article (Faculty180)

cited authors

  • Royfman, Rachel; Whiteley, Emma; Noe, Olivia; Morand, Susan; Creeden, Justin; Stanbery, Laura; Hamouda, Danae; Nemunaitis, John


  • Patients who have mutations of the genes  or  are at an increased risk for developing breast and ovarian cancer. function as tumor suppressor genes, responsible for regulating DNA repair, and play an essential role in homologous recombination. Mutation of results in homologous recombination deficiency and genomic instability which drives oncogenesis and cancer proliferation. Recently, gene expression has been implicated in regulating immune response. Here we discuss the signaling pathway of BRCA1/2 in relation to breast and ovarian cancer, with emphasis on how dysregulation facilitates the path to malignancy and current treatment options.

publication date

  • 2021

published in

start page

  • 2817

end page

  • 2830


  • 17